| Patent | Date |
|---|
Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
Grant 11,357,777 - Im , et al. June 14, 2 | 2022-06-14 |
Methods Of Treating Upper Gastrointestinal Disorders In Ppi Refractory Gerd
App 20220133777 - Lavins; Bernard Joseph ; et al. | 2022-05-05 |
sGC stimulators
Grant 11,207,323 - Nakai , et al. December 28, 2 | 2021-12-28 |
Methods Of Treating Upper Gastrointestinal Disorders In Ppi Refractory Gerd
App 20210290662 - Lavins; Bernard Joseph ; et al. | 2021-09-23 |
sGC STIMULATORS
App 20210214364 - Renhowe; Paul Allan ; et al. | 2021-07-15 |
USE OF sGC STIMULATORS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH)
App 20210161893 - Im; G-Yoon Jamie ; et al. | 2021-06-03 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20210046021 - JERUSSI; Thomas ; et al. | 2021-02-18 |
sGC STIMULATORS
App 20200316065 - Nakai; Takashi ; et al. | 2020-10-08 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 10,702,486 - Jerussi , et al. | 2020-07-07 |
Method of Detecting and Quantifying Bile Acid from Saliva
App 20200138854 - Currie; Mark G. ; et al. | 2020-05-07 |
sGC stimulators
Grant 10,639,308 - Nakai , et al. | 2020-05-05 |
Methods Of Treating Upper Gastrointestinal Disorders In Ppi Refractory Gerd
App 20200113931 - Lavins; Bernard Joseph ; et al. | 2020-04-16 |
Compositions for colon cleansing and the treatment of gastrointestinal disorders
Grant 10,618,938 - Currie , et al. | 2020-04-14 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20200000746 - JERUSSI; Thomas ; et al. | 2020-01-02 |
sGC stimulators
Grant 10,517,874 - Nakai , et al. Dec | 2019-12-31 |
USE OF sGC STIMULATORS FOR THE TREATMENT OF ESOPHAGEAL MOTILITY DISORDERS
App 20190381039 - Currie; Mark G. | 2019-12-19 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 10,328,036 - Jerussi , et al. | 2019-06-25 |
sGC STIMULATORS
App 20190167679 - Nakai; Takashi ; et al. | 2019-06-06 |
sGC stimulators
Grant 10,183,021 - Nakai , et al. Ja | 2019-01-22 |
USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION
App 20180344735 - Carlson; Kenneth E. ; et al. | 2018-12-06 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20180333373 - Jerussi; Thomas ; et al. | 2018-11-22 |
Compositions for Colon Cleansing and the Treatment of Gastrointestinal Disorders
App 20180148476 - Currie; Mark G. ; et al. | 2018-05-31 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 9,907,764 - Jerussi , et al. March 6, 2 | 2018-03-06 |
Methods Of Treating Upper Gastrointestinal Disorders In Ppi Refractory Gerd
App 20180015118 - Lavins; Bernard Joseph ; et al. | 2018-01-18 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 9,840,536 - Currie , et al. December 12, 2 | 2017-12-12 |
Compositions Comprising Bile Acid Sequestrants For Treating Esophageal Disorders
App 20170290767 - CURRIE; Mark G. | 2017-10-12 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20170157067 - JERUSSI; Thomas ; et al. | 2017-06-08 |
sGC STIMULATORS
App 20170136019 - NAKAI; Takashi ; et al. | 2017-05-18 |
sGC STIMULATORS
App 20170137439 - NAKAI; Takashi ; et al. | 2017-05-18 |
Treatments for gastrointestinal disorders
Grant 9,650,417 - Currie , et al. May 16, 2 | 2017-05-16 |
Treatments for gastrointestinal disorders
Grant 9,617,305 - Currie , et al. April 11, 2 | 2017-04-11 |
sGC stimulators
Grant 9,586,937 - Nakai , et al. March 7, 2 | 2017-03-07 |
sGC STIMULATORS
App 20160375022 - NAKAI; Takashi ; et al. | 2016-12-29 |
Treatments for gastrointestinal disorders
Grant 9,527,887 - Currie , et al. December 27, 2 | 2016-12-27 |
sGC STIMULATORS
App 20160347738 - NAKAI; Takashi ; et al. | 2016-12-01 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 9,498,452 - Jerussi , et al. November 22, 2 | 2016-11-22 |
Use Of Sgc Stimulators For The Treatment Of Neuromuscular Disorders
App 20160324856 - LONG; Kimberly Kafadar ; et al. | 2016-11-10 |
sGC stimulators
Grant 9,481,689 - Nakai , et al. November 1, 2 | 2016-11-01 |
Delayed Release Compositions of Linaclotide
App 20160310559 - Fretzen; Angelika ; et al. | 2016-10-27 |
Sgc Stimulators
App 20160311826 - RENHOWE; Paul Allan ; et al. | 2016-10-27 |
Treatments For Disorders Using Guanylate Cyclase C Agonists
App 20160213739 - Currie; Mark G. ; et al. | 2016-07-28 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20160168201 - Currie; Mark G. ; et al. | 2016-06-16 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20160136111 - Jerussi; Thomas ; et al. | 2016-05-19 |
Treatments for gastrointestinal disorders
Grant 9,303,066 - Currie , et al. April 5, 2 | 2016-04-05 |
Compositions comprising bile acid sequestrants for treating esophageal disorders
Grant 9,205,094 - Currie December 8, 2 | 2015-12-08 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 9,072,699 - Jerussi , et al. July 7, 2 | 2015-07-07 |
Treatments for Gastrointestinal Disorders
App 20150119328 - Currie; Mark G. ; et al. | 2015-04-30 |
Methods Of Treating Alopecia And Acne
App 20150080381 - Currie; Mark G. ; et al. | 2015-03-19 |
Treatments of gastrointestinal disorders
Grant 8,946,158 - Currie , et al. February 3, 2 | 2015-02-03 |
Treatments For Gastrointestinal Disorders
App 20150030697 - Currie; Mark G. ; et al. | 2015-01-29 |
Treatments for Gastrointestinal Disorders
App 20140348942 - Currie; Mark G. ; et al. | 2014-11-27 |
Treatments for Gastrointestinal Disorders
App 20140342996 - Currie; Mark G. ; et al. | 2014-11-20 |
Indole compounds
Grant 8,884,020 - Talley , et al. November 11, 2 | 2014-11-11 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20140329765 - Currie; Mark G. ; et al. | 2014-11-06 |
Treatments For Gastrointestinal Disorders
App 20140323397 - Currie; Mark G. ; et al. | 2014-10-30 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20140296163 - Currie; Mark G. ; et al. | 2014-10-02 |
Treatments for Gastrointestinal Disorders
App 20140256634 - Currie; Mark G. ; et al. | 2014-09-11 |
Treatments for Gastrointestinal Disorders
App 20140179607 - Currie; Mark G. ; et al. | 2014-06-26 |
Treatments for gastrointestinal disorders
Grant 8,735,360 - Currie , et al. May 27, 2 | 2014-05-27 |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE
App 20140128474 - JERUSSI; Thomas ; et al. | 2014-05-08 |
Carbonate and carbamate modified forms of glucocorticoids in combination with .beta..sub.2 adrenergic agonists
Grant 8,710,036 - Currie , et al. April 29, 2 | 2014-04-29 |
Compositions And Methods For Treating Or Preventing Gastrointestinal Disorders And Gerd-related Respiratory Disorders
App 20140105851 - CURRIE; Mark G. | 2014-04-17 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,658,700 - Jerussi , et al. February 25, 2 | 2014-02-25 |
Treatments of Gastrointestinal Disorders
App 20140024593 - Currie; Mark G. ; et al. | 2014-01-23 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20130338063 - Currie; Mark G. ; et al. | 2013-12-19 |
Carbonate And Carbamate Modified Forms Of Glucocorticoids In Combination With B2 Adrenergic Agonists
App 20130244988 - CURRIE; Mark G. ; et al. | 2013-09-19 |
Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain
App 20130224151 - Pearson; James Philip ; et al. | 2013-08-29 |
Treatments for gastrointestinal disorders
Grant 8,507,447 - Currie , et al. August 13, 2 | 2013-08-13 |
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20130158125 - Jerussi; Thomas ; et al. | 2013-06-20 |
Compositions And Methods For Treating Or Preventing Metabolic Syndrome And Related Diseases And Disorders
App 20130156720 - Currie; Mark G. | 2013-06-20 |
Compositions And Methods For Treating Or Preventing Gastrointestinal Disorders And Gerd-related Respiratory Disorders
App 20130129660 - CURRIE; Mark G. | 2013-05-23 |
Treatments for Gastrointestinal Disorders
App 20130130995 - Currie; Mark G. ; et al. | 2013-05-23 |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
Grant 8,445,470 - Currie , et al. May 21, 2 | 2013-05-21 |
Soluble Guanylate Cyclase (sgc) Modulators For Treatment Of Lipid Related Disorders
App 20130123354 - CURRIE; Mark G. ; et al. | 2013-05-16 |
Treatments for Gastrointestinal Disorders
App 20130085107 - Currie; Mark G. ; et al. | 2013-04-04 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,344,030 - Jerussi , et al. January 1, 2 | 2013-01-01 |
Methods And Compositions For The Treatment Of Gastrointestinal Disorders
App 20120283411 - Currie; Mark G. ; et al. | 2012-11-08 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20120196797 - Currie; Mark G. ; et al. | 2012-08-02 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20120172325 - Currie; Mark G. | 2012-07-05 |
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20120136065 - JERUSSI; Thomas P. ; et al. | 2012-05-31 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20120108525 - CURRIE; MARK G. ; et al. | 2012-05-03 |
Methods And Compositions For The Treatment Of Gastrointestinal Disorders
App 20120088902 - Currie; Mark G. ; et al. | 2012-04-12 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,134,029 - Jerussi , et al. March 13, 2 | 2012-03-13 |
Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
App 20120040025 - Currie; Mark G. ; et al. | 2012-02-16 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 8,110,553 - Currie , et al. February 7, 2 | 2012-02-07 |
Methods And Compositions For The Treatment Of Fluid Retention Disorders
App 20120028897 - Currie; Mark G. ; et al. | 2012-02-02 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 8,101,579 - Currie , et al. January 24, 2 | 2012-01-24 |
Compounds and methods for the treatment of asthma
Grant 8,088,935 - Pearson , et al. January 3, 2 | 2012-01-03 |
Compositions And Methods Of Use For Treating Or Preventing Lipid Related Disorders
App 20110160225 - Currie; Mark G. ; et al. | 2011-06-30 |
Useful indole compounds
Grant 7,960,544 - Bartolini , et al. June 14, 2 | 2011-06-14 |
Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
App 20110129433 - Currie; Mark G. | 2011-06-02 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20110124583 - Currie; Mark G. ; et al. | 2011-05-26 |
Treatments of Gastrointestinal Disorders
App 20110118184 - Currie; Mark G. ; et al. | 2011-05-19 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20110118195 - Currie; Mark G. ; et al. | 2011-05-19 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,910,546 - Currie , et al. March 22, 2 | 2011-03-22 |
Compositions and Methods for Reducing the Toxicity of Certain Toxins
App 20100310541 - Kessler; Marco ; et al. | 2010-12-09 |
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20100292340 - JERUSSI; Thomas P. ; et al. | 2010-11-18 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20100234301 - Currie; Mark G. ; et al. | 2010-09-16 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 7,790,772 - Jerussi , et al. September 7, 2 | 2010-09-07 |
Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
App 20100215779 - Currie; Mark G. ; et al. | 2010-08-26 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,772,188 - Currie , et al. August 10, 2 | 2010-08-10 |
Indole Compounds
App 20100197708 - Talley; John Jeffrey ; et al. | 2010-08-05 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,745,409 - Currie , et al. June 29, 2 | 2010-06-29 |
Soluble Guanylate Cyclase (sgc) Modulators For Treatment Of Lipid Related Disorders
App 20100144864 - Currie; Mark G. ; et al. | 2010-06-10 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,704,947 - Currie , et al. April 27, 2 | 2010-04-27 |
Pharmaceutical Formulation For Parenteral Administration
App 20100010046 - Currie; Mark G. ; et al. | 2010-01-14 |
Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders
App 20090312302 - CURRIE; Mark G. | 2009-12-17 |
Methods And Composition For The Treatment Of Gastrointestinal Disorders
App 20090305993 - Currie; Mark G. | 2009-12-10 |
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20090292026 - Jerussi; Thomas P. ; et al. | 2009-11-26 |
Useful Indole Compounds
App 20090264653 - Bartolini; Wilmin ; et al. | 2009-10-22 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20090253634 - Currie; Mark G. ; et al. | 2009-10-08 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20090233882 - Currie; Mark G. | 2009-09-17 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 7,589,237 - Jerussi , et al. September 15, 2 | 2009-09-15 |
Methods And Compositions For The Treatment Of Gastrointestinal Disorders
App 20090192083 - Currie; MARK G. | 2009-07-30 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20090191611 - Currie; Mark G. ; et al. | 2009-07-30 |
Carbonate And Carbamate Modified Forms Of Glucocorticoids In Combination With B2 Adrenergic Agonists
App 20090163456 - Currie; Mark G. ; et al. | 2009-06-25 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20090062207 - Currie; Mark G. ; et al. | 2009-03-05 |
Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders
App 20090054319 - Talley; John Jeffrey ; et al. | 2009-02-26 |
Compositions And Methods Of Use For Treating Or Preventing Lipid Related Disorders
App 20090054450 - CURRIE; Mark G. ; et al. | 2009-02-26 |
Method for treating congestive heart failure and other disorders
Grant 7,494,979 - Currie , et al. February 24, 2 | 2009-02-24 |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
App 20090005534 - Currie; Mark G. ; et al. | 2009-01-01 |
Carbonate and carbamate modified forms of glucocorticoids in combination with .beta..sub.2 adrenergic agonists
Grant 7,468,362 - Currie , et al. December 23, 2 | 2008-12-23 |
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20080280993 - Jerussi; Thomas P. ; et al. | 2008-11-13 |
Methods And Compositions For The Treatment Of Gastrointestinal Disorders
App 20080227685 - Currie; Mark G. ; et al. | 2008-09-18 |
Fatty Acid Modified Forms of Glucocorticoids
App 20080221072 - Currie; Mark G. ; et al. | 2008-09-11 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 7,423,179 - Jerussi , et al. September 9, 2 | 2008-09-09 |
4-biarylyl-1-phenylazetidin-2-ones
App 20080167255 - Martinez; Eduardo J. ; et al. | 2008-07-10 |
Fatty acid modified forms of glucocorticoids
Grant 7,390,796 - Currie , et al. June 24, 2 | 2008-06-24 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,371,727 - Currie , et al. May 13, 2 | 2008-05-13 |
Carbonate And Carbamate Modified Forms Of Glucocorticoids In Combination With B2 Adrenergic Agonists
App 20080103119 - Currie; Mark G. ; et al. | 2008-05-01 |
Methods And Compositions For The Treatment Of Gastrointestinal disorders
App 20080025966 - Currie; Mark G. | 2008-01-31 |
4-Biarylyl-1-phenylazetidin-2-ones
Grant 7,320,972 - Martinez , et al. January 22, 2 | 2008-01-22 |
Selective Cox-2 Inhibitors
App 20070293542 - Cali; Brian M. ; et al. | 2007-12-20 |
Methods and compositions for the treatment of gastrointestinal disorders
Grant 7,304,036 - Currie , et al. December 4, 2 | 2007-12-04 |
Compounds and methods for the treatment of asthma
App 20070249644 - Pearson; James ; et al. | 2007-10-25 |
Useful indole compounds
App 20070203209 - Bartolini; Wilmin ; et al. | 2007-08-30 |
Carbonate and carbamate modified forms of glucocorticoids in combination with B.sub.2 adrenergic agonists
Grant 7,253,156 - Currie , et al. August 7, 2 | 2007-08-07 |
Modulators of CRTH2 Activity
App 20070161698 - Chien; Yueh-Tyng ; et al. | 2007-07-12 |
Modulators of CRTH2 activity
Grant 7,205,329 - Chien , et al. April 17, 2 | 2007-04-17 |
Compositions comprising and methods of using norfluoxetine
App 20070078188 - Currie; Mark G. ; et al. | 2007-04-05 |
Fatty acid modified forms of glucocorticoids
App 20070060555 - Currie; Mark G. ; et al. | 2007-03-15 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20070010450 - Currie; Mark G. ; et al. | 2007-01-11 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20060281682 - Currie; Mark G. ; et al. | 2006-12-14 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20060258593 - Currie; Mark G. ; et al. | 2006-11-16 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
App 20060216799 - Jerussi; Thomas P. ; et al. | 2006-09-28 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
Grant 7,105,699 - Jerussi , et al. September 12, 2 | 2006-09-12 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
Grant 7,087,785 - Jerussi , et al. August 8, 2 | 2006-08-08 |
Modulators of FAAH
App 20060167075 - Pearson; James Philip ; et al. | 2006-07-27 |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
App 20060148775 - Currie; Mark G. ; et al. | 2006-07-06 |
Modulators of CRTH2 activity
App 20060135591 - Chien; Yueh-Tyng ; et al. | 2006-06-22 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
App 20060128993 - Jerussi; Thomas P. ; et al. | 2006-06-15 |
Method and compositions for the treatment of gastrointestinal disorders
App 20060094658 - Currie; Mark G. ; et al. | 2006-05-04 |
Methods of using norfluoxetine
Grant 7,034,059 - Currie , et al. April 25, 2 | 2006-04-25 |
Carbonate and carbamate modified forms of glucocorticoids
Grant 7,018,995 - Currie , et al. March 28, 2 | 2006-03-28 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
App 20060014982 - Jerussi; Thomas P. ; et al. | 2006-01-19 |
Synthesis of COX-2 and FAAH inhibitors
App 20050234244 - Bartolini, Wilmin ; et al. | 2005-10-20 |
Modulators of CRTH2, COX-2 and FAAH
App 20050234030 - Bartolini, Wilmin ; et al. | 2005-10-20 |
Ion-exchange resin/enzyme activity assay
Grant 6,927,037 - Kasten , et al. August 9, 2 | 2005-08-09 |
Compositions and methods for treating or preventing hearing impairment
App 20050101534 - Zepp, Charles M. ; et al. | 2005-05-12 |
COX-2 and FAAH inhibitors
App 20050032747 - Bartolini, Wilmin ; et al. | 2005-02-10 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20050020811 - Currie, Mark G. ; et al. | 2005-01-27 |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
App 20050009798 - Currie, Mark G. ; et al. | 2005-01-13 |
Methods for the protection of memory and cognition
App 20050004104 - Cali, Brian M. ; et al. | 2005-01-06 |
Methods and compositions for the treatment of gastrointestinal disorders
App 20040266989 - Currie, Mark G. ; et al. | 2004-12-30 |
Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
App 20040266864 - Bush, Larry R. ; et al. | 2004-12-30 |
Fatty acid modified forms of glucocorticoids
App 20040235811 - Currie, Mark G. ; et al. | 2004-11-25 |
Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
App 20040143017 - Manning, Pamela T. ; et al. | 2004-07-22 |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetra- hydro-1-napthalenamine and its formamide
App 20040092605 - Jerussi, Thomas P. ; et al. | 2004-05-13 |
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetr- ahydro-N-methyl-1-napthalenamine
App 20040087661 - Jerussi, Thomas P. ; et al. | 2004-05-06 |
Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
Grant 6,653,350 - Manning , et al. November 25, 2 | 2003-11-25 |
Carbonate and carbamate modified forms of glucocorticoids
App 20030176407 - Currie, Mark G. ; et al. | 2003-09-18 |
D-amino acid oxidase inhibitors for learning and memory
App 20030162825 - Heefner, Donald L. ; et al. | 2003-08-28 |
Methods of using norfluoxetine
App 20030096019 - Currie, Mark G. ; et al. | 2003-05-22 |
Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
App 20030087963 - Senanayake, Chris H. ; et al. | 2003-05-08 |
Compositions and methods for management of serotonin-mediated disorders
App 20030083338 - Currie, Mark G. ; et al. | 2003-05-01 |
(S)-hydroxynefazodone antipsychotic therapy
App 20020077326 - Currie, Mark G. ; et al. | 2002-06-20 |
Ion-exchange resin / enzyme activity assay
App 20020072082 - Karsten, Thomas P. ; et al. | 2002-06-13 |
(R)-hydroxynefazodone antipsychotic therapy
App 20020058675 - Currie, Mark G. ; et al. | 2002-05-16 |
Amidino derivatives useful as nitric oxide synthase inhibitors
Grant 6,046,211 - Hansen, Jr. , et al. April 4, 2 | 2000-04-04 |
Human guanylin
Grant 5,969,097 - Wiegand , et al. October 19, 1 | 1999-10-19 |
Amidino dervatives useful as nitric oxide synthase inhibitors
Grant 5,854,234 - Hansen, Jr. , et al. December 29, 1 | 1998-12-29 |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
Grant 5,792,758 - Tjoeng , et al. August 11, 1 | 1998-08-11 |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
Grant 5,707,984 - Tjoeng , et al. January 13, 1 | 1998-01-13 |
Amidine derivatives useful as platelet aggregation inhibitors and vasodilators
Grant 5,674,894 - Currie , et al. October 7, 1 | 1997-10-07 |
Human uroguanylin
Grant 5,489,670 - Currie , et al. February 6, 1 | 1996-02-06 |
Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
Grant 5,140,102 - Currie August 18, 1 | 1992-08-18 |
| 